| Lastest Insider Transactions Of Keros Therapeutics, Inc. ( KROS ) | |||||||||
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| KROS | Keros Therapeutics, Inc. | GORDON CARL L | Directior | 2024-08-13 | Sell | 250,000 | 44.01 | 11,002,500 | 2024-08-15 17:06:51 |
| KROS | Keros Therapeutics, Inc. | ORBIMED ADVISORS LLC | Directior | 2024-08-13 | Sell | 250,000 | 44.01 | 11,002,500 | 2024-08-15 17:01:28 |
| KROS | Keros Therapeutics, Inc. | Regnante Keith | Chief Financial Officer | 2023-11-04 | Sell | 40,000 | 45.29 | 1,811,600 | 2024-01-08 16:43:46 |
| KROS | Keros Therapeutics, Inc. | Regnante Keith | Chief Financial Officer | 2023-11-04 | Option Exercise | 40,000 | 16.00 | 640,000 | 2024-01-08 16:43:46 |
| KROS | Keros Therapeutics, Inc. | Regnante Keith | Chief Financial Officer | 2023-06-08 | Sell | 40,000 | 46.61 | 1,864,239 | 2023-06-12 16:13:40 |
| KROS | Keros Therapeutics, Inc. | Regnante Keith | Chief Financial Officer | 2023-06-08 | Option Exercise | 40,000 | 16.00 | 640,000 | 2023-06-12 16:13:40 |
| KROS | Keros Therapeutics, Inc. | Seehra Jasbir | Chief Executive Officer | 2023-04-08 | Option Exercise | 4,000 | 0.48 | 1,920 | 2023-04-11 16:05:25 |
| KROS | Keros Therapeutics, Inc. | Knowles Julius | Directior | 2020-04-13 | Buy | 1,191 | 20.98 | 24,987 | 2023-01-20 16:32:18 |
